Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Cash from Investing Activities of -$159.0 million for Q1 2026, down 50.0% year-over-year from -$318.0 million in Q1 2025, and up 50.62% quarter-over-quarter from -$322.0 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$159.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 50.0% year-over-year to -$159.0 million; the TTM figure through Mar 2026 stood at -$2.0 billion (down 153.87% YoY), while the FY2025 annual figure was -$2.0 billion, down 122.46% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$159.0 million, up from -$322.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$81.1 million in Q1 2022, with the low at -$1.4 billion in Q2 2025.
- The 5-year median for Cash from Investing Activities is -$165.6 million (2023), against an average of -$254.3 million.
- Peak annual rise in Cash from Investing Activities reached 45.64% in 2025, while the deepest fall reached 460.49% in 2025.
- Zimmer Biomet Holdings' Cash from Investing Activities stood at -$112.5 million in 2022, then tumbled by 96.27% to -$220.8 million in 2023, then tumbled by 31.88% to -$291.2 million in 2024, then fell by 10.58% to -$322.0 million in 2025, then soared by 50.62% to -$159.0 million in 2026.
- Business Quant data shows ZBH's Cash from Investing Activities at -$159.0 million in Q1 2026, -$322.0 million in Q4 2025, and -$163.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -190.80 Mn |
| Jun 30, 2026 | -190.80 Mn |
| Mar 31, 2026 | -159.00 Mn |
| Mar 31, 2026 | -159.00 Mn |
| Dec 31, 2025 | -322.00 Mn |
| Dec 31, 2025 | -322.00 Mn |
| Sep 30, 2025 | -163.30 Mn |
| Sep 30, 2025 | -163.30 Mn |
| Jun 30, 2025 | -1.38 Bn |
| Jun 30, 2025 | -1.38 Bn |
| Mar 31, 2025 | -106.00 Mn |
| Mar 31, 2025 | -106.00 Mn |
| Dec 31, 2024 | -291.20 Mn |
| Dec 31, 2024 | -291.20 Mn |
| Sep 30, 2024 | -154.90 Mn |
| Sep 30, 2024 | -154.90 Mn |
| Jun 30, 2024 | -247.00 Mn |
| Jun 30, 2024 | -247.00 Mn |
| Mar 31, 2024 | -195.00 Mn |
| Mar 31, 2024 | -195.00 Mn |